Search

Displaying results 8201 - 8210 of 10000 in total
  1. Drug

    DA-6886

    go.drugbank.com/drugs/DB12853
    Investigational

    DA-6886 has been used in trials studying the treatment of Irritable Bowel Syndrome.

    Categories: Heterocyclic Compounds, 1-Ring
  2. Drug

    Apricitabine

    go.drugbank.com/drugs/DB12855
    Investigational

    Apricitabine has been used in trials studying the treatment of HIV Infections.

    Categories: Heterocyclic Compounds, 1-Ring
  3. Drug

    GS-9256

    go.drugbank.com/drugs/DB12876
    Investigational

    GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.

  4. Drug

    Indole-3-carbinol

    go.drugbank.com/drugs/DB12881
    Investigational

    Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).

    Categories: Heterocyclic Compounds, 2-Ring, Compounds used in a research, industrial, or household setting
  5. Drug

    Lavoltidine

    go.drugbank.com/drugs/DB12884
    Investigational

    Lavoltidine has been used in trials studying the diagnostic of Reflux, Gastroesophageal and Gastroesophageal Reflux Disease.

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Tazemetostat

    go.drugbank.com/drugs/DB12887
    ApprovedInvestigational

    Tazemetostat is a methyltransferase inhibitor used to treat metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. … [L11476] Tazemetostat was first named in literature as EPZ-6438.[A190363] Tazemetaostat was granted FDA approval on 23 January 2020.[L11476]

    Categories: MATE 2-K Inhibitors, MATE 1 Inhibitors
  7. Drug

    Ezutromid

    go.drugbank.com/drugs/DB12888
    Investigational

    Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.

    Synonyms: 5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo(d)oxazole, Benzoxazole, 5-(ethylsulfonyl)-2-(2-naphthalenyl)-Categories: Heterocyclic Compounds, 2-Ring
  8. Drug

    Sacituzumab govitecan

    go.drugbank.com/drugs/DB12893
    ApprovedInvestigational

    [A193671] One such ADC is sacituzumab govitecan, which combines a humanized anti-trophoblast cell-surface antigen 2 (TROP-2) antibody with the topoisomerase I inhibitor SN-38. … As a targeted cytotoxic agent, it is hoped to provide similar efficacy with reduced adverse effects.

    Categories: Trop-2-Directed Monoclonal AntibodiesProducts: TRODELVY®, TRODELVY 200 MG İNFÜZYONLUK ÇÖZELTİ KONSANTRESİ İÇİN TOZ, 1 ADET
  9. Drug

    PSI-352938

    go.drugbank.com/drugs/DB12896
    Investigational

    PSI-352938 has been used in trials studying the treatment of Hepatitis C and Hepatitis C, Chronic.

  10. Drug

    TT-301

    go.drugbank.com/drugs/DB12899
    Investigational

    TT301 has been used in trials studying the treatment of Traumatic Brain Injury.

    Categories: Heterocyclic Compounds, 1-Ring